EUCTR2008-002064-34-Outside-EU/EEA进行中（未招募）不适用
A 6-MONTH, OPEN-LABEL, MULTI-CENTER, FLEXIBLE-DOSE EXTENSION STUDY TO THE B2061014 STUDY TO EVALUATE THE SAFETY, TOLERABILITY AND EFFICACY OF DESVENLAFAXINE SUCCINATE SUSTAINED-RELEASE (DVS SR) TABLETS IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER.
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- Pfizer Inc.
- 入组人数
- 269
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Completed study B2061014 and who in the investigator’s opinion would benefit from long term treatment with DVS SR.
- •Willingness and ability to comply with scheduled visits, treatment plan and procedures.
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 269
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Subject requires precaution against suicide.
- •Subject not in generally healthy medical condition.
- •Poor compliance with study drug or study procedures during participation in study B2061014.
研究者
相似试验
进行中（未招募）
不适用
Study Evaluating Desvenlafaxine Succinate Sustained-Release Tablets (DVS SR) In The Treatment Of Child and Adolescent Outpatients With Major Depressive DisorderMajor Depressive DisorderEUCTR2008-002067-14-Outside-EU/EEAWyeth Research40
进行中（未招募）
1 期
Desvenlafaxine Succinate Sustained-Release (DVS SR) In The Treatment Of Children And Adolescent Outpatients With Major Depressive DisorderMajor Depressive DisorderEUCTR2008-001876-67-Outside-EU/EEAPfizer Inc.283
已完成
不适用
A 26-WEEK, MULTI-CENTER, OPEN-LABEL, FLEXIBLE DOSE, LONG-TERM SAFETY TRIAL OF ASENAPINE IN ADOLESCENT SUBJECTS WITH SCHIZOPHRENIA-F20F20PER-055-10SCHERING PLOUGH RESEARCH INSTITUTE,
进行中（未招募）
1 期
A 6-Month, Open-Label, Flexible-Dosage (150 to 200 mg/day) Extension Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I DisorderMajor Depression Associated With Bipolar I DisorderEUCTR2009-016648-38-FRCephalon, Inc.867
进行中（未招募）
不适用
The purpose of this study is to look at the safety, effectiveness, and tolerability of armodafinil when used for 6 months with mood stabilizers in subjects with major depression associated with bipolar I disorderMajor Depression Associated With Bipolar I DisorderMedDRA version: 14.1Level: LLTClassification code 10004911Term: Bipolar affective disorder, depressedSystem Organ Class: 100000004873EUCTR2009-016648-38-HUCephalon, Inc.370